Přehled o publikaci
2023
Hide and seek retroelement activity in hematological malignancies.
VOLAKHAVA, Anastasiya, Šárka PAVLOVÁ, Kristýna ZÁVACKÁ, Karol PÁL, Marcela KRZYŽÁNKOVÁ et. al.Basic information
Original name
Hide and seek retroelement activity in hematological malignancies.
Authors
VOLAKHAVA, Anastasiya, Šárka PAVLOVÁ, Kristýna ZÁVACKÁ, Karol PÁL, Marcela KRZYŽÁNKOVÁ, Hana SYNÁČKOVÁ, Šárka POSPÍŠILOVÁ, Ilgar MAMEDOV and Karla PLEVOVÁ
Edition
EMBL Conference Cancer Genomics 2023, Heidelberg, Německo, 2023
Other information
Language
English
Type of outcome
Konferenční abstrakta
Country of publisher
Germany
Confidentiality degree
is not subject to a state or trade secret
References:
Organization
Středoevropský technologický institut – Repository – Repository
Keywords in English
Retroelements; Long Interspersed Nucleic Elements; chronic lymphocytic leukemia
Links
LX22NPO5102, research and development project.
Changed: 28/3/2024 04:03, RNDr. Daniel Jakubík
Abstract
V originále
Retroelements (REs), which function via a “copy-and-paste” mechanism, comprise nearly half of the human genome. The Long Interspersed Nucleic Elements, type 1 (LINE-1 or L1) are the only active autonomous REs. They are able to retrotranspose other RNAs including Alu and SVA REs, and occasionally protein-coding RNAs. Retroelements are silenced via multiple mechanisms, but genomic instability of cancer cells often leads to aberrant disruption of RE repression and enhances their transposition activity. The main goal of our research is to explore RE activity in chronic lymphocytic leukemia (CLL) and myelodysplastic syndrome (MDS) and to study the impact of therapy and TP53 inactivation on RE activity. To identify tumor-specific RE insertions, we adopted a highly sensitive amplicon NGS protocol for localizing insertions of REs from Alu-Ya5, Alu-Yb8, or L1-HS families into their target genomic regions. In total, 99 samples from 17 MDS and 21 CLL patients, and 60 samples from 4 leukemic cell lines were analyzed.